C16:0 cersoc (D18 :2 (4E 8Z)/16 : 0)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

General description

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

Packaging

5 mL Amber Glass Screw Cap Vial (860692P-1mg)